Condition (MeSH)
Sex Chromosome Aberrations
ClinicalTrials.gov lists 11 trials for Sex Chromosome Aberrations or a narrower condition beneath it. Natera, Inc. has the most among industry and government lead sponsors, with 6.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
10 of the 11 trials are tagged with Sex Chromosome Aberrations itself; the rest are tagged with a narrower condition beneath it.
When did Sex Chromosome Aberrations trials start? (9)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2024 | 1 |
| 2022 | 1 |
| 2015 | 1 |
| 2014 | 1 |
| 2013 | 1 |
| 2012 | 3 |
| 2011 | 1 |
| 2007 | 1 |
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 11 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Sex Chromosome Aberrations trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 1 |
| Observational | 10 |
How many Sex Chromosome Aberrations trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Enrolling by invitation | 1 |
| Completed | 8 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Sex Chromosome Aberrations trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Natera, Inc. | 6 |
| BillionToOne Inc. | 1 |
| National Eye Institute (NEI) | 1 |
Interventions as named in the registry (1)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Testosteron | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Sex Chromosome Aberrations? (47)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Influences of sex chromosome aneuploidy on height, weight, and body mass index in human childhood and adolescence. | American journal of medical genetics. Part A | 2024 | Yes |
| X chromosome dosage and the genetic impact across human tissues. | Genome medicine | 2023 | Yes |
| The epidemiology of sex chromosome abnormalities. | American journal of medical genetics. Part C, Seminars in medical genetics | 2020 | Yes |
| MCT8 deficiency: extrapyramidal symptoms and delayed myelination as prominent features. | Journal of child neurology | 2013 | Yes |
| Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. | Prenatal diagnosis | 2013 | Yes |
Showing 5 of 47 publications.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Sex-chromosome anomaly syndrome | 98155 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Sex-chromosome anomaly syndrome | 98155 | Exact | Orphadata Science knowledge files, Product 1 |
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and prevalence.